for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Syneos Health Inc

SYNH.OQ

Latest Trade

51.58USD

Change

0.29(+0.57%)

Volume

1,289,508

Today's Range

50.59

 - 

51.76

52 Week Range

30.34

 - 

74.22

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
51.29
Open
50.92
Volume
1,289,508
3M AVG Volume
15.67
Today's High
51.76
Today's Low
50.59
52 Week High
74.22
52 Week Low
30.34
Shares Out (MIL)
104.24
Market Cap (MIL)
5,358.50
Forward P/E
16.08
Dividend (Yield %)
--

Next Event

Q3 2020 Syneos Health Inc Earnings Release

Latest Developments

More

Syneos Health Announces Pricing Of Secondary Offering Of Common Stock

Syneos Health Announces Secondary Offering Of Common Stock

Syneos Health Reports Q2 Adjusted Earnings Per Share $0.58

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Syneos Health Inc

Syneos Health Inc. is a fully integrated biopharmaceutical solutions providing company. The Company offers both stand-alone and integrated biopharmaceutical product development solutions through its Contract Research Organization (CRO) and Contract Commercial Organization (CCO), ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. It brings together approximately 24,000 clinical and commercial professionals with the ability to support customers in more than 110 countries. Together it shares insights, leverages latest technologies and apply advanced business practices to deliver important therapies to patients.

Industry

Biotechnology & Drugs

Contact Info

1030 Sync Street

MORRISVILLE, NC

27560

United States

+1.919.8769300

https://www.syneoshealth.com/

Executive Leadership

John M. Dineen

Independent Chairman of the Board

Alistair Macdonald

Chief Executive Officer, Director

Jason Meggs

Chief Financial Officer

Paul D. Colvin

President - Clinical Solutions

Michelle Keefe

President - Commercial Solutions

Key Stats

2.07 mean rating - 14 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

1.9K

2018

4.4K

2019

4.7K

2020(E)

4.5K
EPS (USD)

2017

2.270

2018

2.870

2019

3.230

2020(E)

3.238
Price To Earnings (TTM)
28.81
Price To Sales (TTM)
1.17
Price To Book (MRQ)
1.78
Price To Cash Flow (TTM)
12.76
Total Debt To Equity (MRQ)
92.82
LT Debt To Equity (MRQ)
89.39
Return on Investment (TTM)
3.20
Return on Equity (TTM)
2.53

Latest News

Latest News

BRIEF-Syneos Health Inc Sees Q2 Adjusted Earnings Per Share $0.48-$0.52

* SYNEOS HEALTH INC SEES Q2 ADJUSTED EARNINGS PER SHARE $0.48 - $0.52 - SEC FILING

BRIEF-Daiichi Sankyo And Syneos Health Form Strategic Coalition For Development Of Daiichi Sankyo’S Adc Oncology Pipeline

* DAIICHI SANKYO AND SYNEOS HEALTH® FORM STRATEGIC COALITION FOR DEVELOPMENT OF DAIICHI SANKYO’S ADC ONCOLOGY PIPELINE

BRIEF-Syneos Health Withdraws Financial Guidance For Year Ending Dec. 31, 2020

* SYNEOS HEALTH INC - EXPECTS AGGREGATE FINANCIAL RESULTS FOR THREE MONTHS ENDED MARCH 31, 2020 TO BE IN LINE WITH ITS PREVIOUSLY ISSUED GUIDANCE RANGE

Deals of the day-Mergers and acquisitions

The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

Exclusive: Syneos Health exploring a sale: sources

Syneos Health Inc <SYNH.O>, a U.S. contract research organization (CRO) that serves the pharmaceutical industry, is exploring a sale, people familiar with the matter said on Monday.

BRIEF-Syneos Health Reports Q4 Adjusted Earnings Per Share $1.03

* SYNEOS HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS

BRIEF-Syneos Health Says Qtrly Adjusted Diluted Earnings Per Share Of $1.03

* QTRLY GAAP REVENUE OF $1,213.0 MILLION, REPRESENTING GROWTH OF 5.9%

BRIEF-Syneos Health Reports Q1 Adjusted Earnings Per Share Of $0.55

* Q1 EARNINGS PER SHARE VIEW $0.51 -- THOMSON REUTERS I/B/E/S

BRIEF-Syneos Health Appoints Jason Meggs As Interim CFO

* SYNEOS HEALTH SAYS APPOINTED JASON MEGGS AS EXECUTIVE VICE PRESIDENT AND INTERIM CHIEF FINANCIAL OFFICER OF CO EFFECTIVE IMMEDIATELY - SEC FILING Source text: (http://bit.ly/2sO58iC) Further company coverage:

BRIEF-Syneos Health Names Lisa van Capelle Chief Human Resources Officer

* SYNEOS HEALTH NAMES LISA VAN CAPELLE CHIEF HUMAN RESOURCES OFFICER Source text for Eikon: Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up